Gordon Murdo
SEC CIK 1642156 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | EVP, Gbl Commercial Ops | 51.2K | — | $7.41M | 33 | 2021-11-02 | 2026-05-07 |
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 19:58 | 2026-05-07 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $331.11 | -615 | 51.2K | -1% | -$203.6K | |
| D | 2026-05-07 21:01 | 2026-05-05 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +3,640 | 52.3K | +7% | $0 |
| D | 2026-05-07 21:01 | 2026-05-06 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $329.59 | -502 | 51.8K | -1.0% | -$165.5K |
| M | 2026-05-05 20:06 | 2026-05-02 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $329.82 | -1,593 | 48.7K | -3% | -$525.4K |
| 2026-03-18 | 2026-03-16 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $366.21 | -6,691 | 50.3K | -12% | -$2.45M | |
| 2026-03-05 | 2026-03-03 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +13.4K | 56.8K | +31% | $0 | |
| 2025-11-13 | 2025-11-12 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | S - Sale | $336.83 | -6,879 | 41.9K | -14% | -$2.32M | |
| D | 2025-05-08 | 2025-05-06 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +3,919 | 50.0K | +9% | $0 |
| M | 2025-05-06 | 2025-05-02 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $283.78 | -1,520 | 46.8K | -3% | -$431.3K |
| 2025-05-02 | 2025-04-30 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $288.56 | -800 | 47.6K | -2% | -$230.8K | |
| 2025-03-19 | 2025-03-17 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $313.71 | -4,039 | 48.4K | -8% | -$1.27M | |
| 2025-03-05 | 2025-03-03 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +8,085 | 52.3K | +18% | $0 | |
| 2025-02-13 | 2025-02-11 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | S - Sale | $294.79 | -8,771 | 44.2K | -17% | -$2.59M | |
| D | 2024-05-09 | 2024-05-07 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +3,529 | 52.7K | +7% | $0 |
| 2024-05-07 | 2024-05-05 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $311.29 | -665 | 49.1K | -1% | -$207.0K | |
| 2024-05-03 | 2024-05-02 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $277.37 | -758 | 49.8K | -1% | -$210.2K | |
| 2024-05-01 | 2024-04-30 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $276.38 | -753 | 50.6K | -1% | -$208.1K | |
| 2024-03-20 | 2024-03-18 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $268.87 | -6,461 | 51.3K | -11% | -$1.74M | |
| 2024-03-08 | 2024-03-06 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +12.9K | 57.6K | +29% | $0 | |
| 2023-08-11 | 2023-08-10 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | S - Sale | $262.43 | -9,558 | 44.3K | -18% | -$2.51M | |
| 2023-05-09 | 2023-05-05 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $231.89 | -623 | 53.9K | -1% | -$144.5K | |
| D | 2023-05-04 | 2023-05-03 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $235.97 | -859 | 54.5K | -2% | -$202.7K |
| D | 2023-05-04 | 2023-05-02 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | A - Grant | $0.00 | +4,237 | 55.3K | +8% | $0 |
| 2023-05-02 | 2023-04-30 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $239.74 | -728 | 51.1K | -1% | -$174.5K | |
| 2023-03-20 | 2023-03-17 | AMGN | Amgen | Gordon Murdo | EVP, Gbl Commercial Ops | F - Tax | $234.57 | -3,978 | 51.8K | -7% | -$933.1K | |
| 2023-03-08 | 2023-03-06 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | A - Grant | $0.00 | +7,947 | 55.6K | +17% | $0 | |
| 2022-08-23 | 2022-08-22 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | G - Gift | $0.00 | -400 | 47.5K | -0.8% | $0 | |
| 2022-05-09 | 2022-05-05 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | F - Tax | $236.10 | -603 | 47.8K | -1% | -$142.4K | |
| D | 2022-05-04 | 2022-05-02 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | A - Grant | $0.00 | +4,330 | 49.2K | +10% | $0 |
| D | 2022-05-04 | 2022-05-03 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | F - Tax | $230.92 | -808 | 48.4K | -2% | -$186.6K |
| 2022-03-22 | 2022-03-18 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | F - Tax | $235.86 | -4,995 | 44.9K | -10% | -$1.18M | |
| 2022-03-03 | 2022-03-01 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | A - Grant | $0.00 | +9,989 | 49.7K | +25% | $0 | |
| 2021-11-03 | 2021-11-02 | AMGN | Amgen | Gordon Murdo | EVP Gbl Commercial Ops | F - Tax | $209.79 | -5,585 | 39.6K | -12% | -$1.17M |
Purchase Sale Sale after option exercise All abbreviations